Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dunbar Ivy

Showing results (231-240 of 252) with videos related to

Pageof 26
Sort By:
The Journal of Pediatrics|October 23, 2021
Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary HypertensionMegan Griffiths, Jun Yang, Dhananjay Vaidya, et al.
Pediatric Research|September 14, 2020
Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survivalMegan Griffiths, Jun Yang, Melanie Nies, et al.
ERJ Open Research|June 30, 2022
<i>COL18A1</i> genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association studyCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
ERJ Open Research|October 15, 2021
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertensionCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
The Journal of Pediatrics|July 27, 2020
Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial HypertensionJenny Y Chen, Megan Griffiths, Jun Yang, et al.
Pulmonary Circulation|March 11, 2024
Actigraphy methodology in the Kids Mod PAH trial: Physical activity as a functional endpoint in pediatric clinical trialsCatherine M Avitabile, Usha S Krishnan, Delphine Yung, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 2, 2019
Differences in pulmonary arterial flow hemodynamics between children and adults with pulmonary arterial hypertension as assessed by 4D-flow CMR studiesMichal Schäfer, D Dunbar Ivy, Steven H Abman, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 24, 2018
Aortic stiffness in adolescent Turner and Marfan syndrome patientsMichal Schäfer, Lorna P Browne, Uyen Truong, et al.
Journal of the American College of Cardiology|July 30, 2021
Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary HypertensionR Mark Grady, Matthew W Canter, Fei Wan, et al.
Pulmonary Circulation|April 15, 2016
Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task ForcesMaria Jesus Del Cerro, Shahin Moledina, Sheila G Haworth, et al.
Pageof 26

Showing results (231-240 of 252) with videos related to

Sort By:
Pageof 26
The Journal of Pediatrics|October 23, 2021
Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary HypertensionMegan Griffiths, Jun Yang, Dhananjay Vaidya, et al.
Pediatric Research|September 14, 2020
Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survivalMegan Griffiths, Jun Yang, Melanie Nies, et al.
ERJ Open Research|June 30, 2022
<i>COL18A1</i> genotypic associations with endostatin levels and clinical features in pulmonary arterial hypertension: a quantitative trait association studyCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
ERJ Open Research|October 15, 2021
The angiostatic peptide endostatin enhances mortality risk prediction in pulmonary arterial hypertensionCatherine E Simpson, Megan Griffiths, Jun Yang, et al.
The Journal of Pediatrics|July 27, 2020
Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial HypertensionJenny Y Chen, Megan Griffiths, Jun Yang, et al.
Pulmonary Circulation|March 11, 2024
Actigraphy methodology in the Kids Mod PAH trial: Physical activity as a functional endpoint in pediatric clinical trialsCatherine M Avitabile, Usha S Krishnan, Delphine Yung, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 2, 2019
Differences in pulmonary arterial flow hemodynamics between children and adults with pulmonary arterial hypertension as assessed by 4D-flow CMR studiesMichal Schäfer, D Dunbar Ivy, Steven H Abman, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 24, 2018
Aortic stiffness in adolescent Turner and Marfan syndrome patientsMichal Schäfer, Lorna P Browne, Uyen Truong, et al.
Journal of the American College of Cardiology|July 30, 2021
Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary HypertensionR Mark Grady, Matthew W Canter, Fei Wan, et al.
Pulmonary Circulation|April 15, 2016
Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task ForcesMaria Jesus Del Cerro, Shahin Moledina, Sheila G Haworth, et al.
Pageof 26